Sponsor
Evommune
Evommune, Inc. is a clinical-stage biotechnology company discovering and developing new ways to treat chronic inflammatory diseases. Our programs are designed to advance therapies in underserved patient populations where a high unmet need remains. We target these pathologies at the source with novel agents that exhibit best-in-class profiles for safety and efficacy, designing therapeutics for patients that aim to go beyond symptomatic relief. Our extensive expertise in immunology, combined with first-hand experience shepherding novel agents through regulatory review, has already benefitted millions of patients.
« Go Back